Form 8-K - Current report:
SEC Accession No. 0001935979-24-000073
Filing Date
2024-09-23
Accepted
2024-09-23 09:11:53
Documents
20
Period of Report
2024-09-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20240923.htm   iXBRL 8-K 32338
2 EX-99.1 exhibit991.htm EX-99.1 25987
6 bhvn-20240923_g1.jpg GRAPHIC 361255
7 bhvn-20240923_g2.jpg GRAPHIC 366854
8 bhvn-20240923_g3.jpg GRAPHIC 384351
9 biohaven_quote.jpg GRAPHIC 539332
10 image1a.jpg GRAPHIC 441584
11 imagea.jpg GRAPHIC 451967
  Complete submission text file 0001935979-24-000073.txt   4764329

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20240923.xsd EX-101.SCH 1922
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20240923_lab.xml EX-101.LAB 21597
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20240923_pre.xml EX-101.PRE 12510
23 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20240923_htm.xml XML 2706
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41477 | Film No.: 241314820
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)